Human tumor sensitivity to 5-fluorouracil influenced by dihydropyrimidine dehydrogenase mRNA in the tumor
Ishikawa, Y.; Kubota, T.; Otani, Y.; Watanabe, M.; Kumai, K.; Kitajima, M.
Nihon Geka Gakkai Zasshi 99(4): 274
1998
ISSN/ISBN: 0301-4894 PMID: 9750075 Document Number: 496649
Document emailed within 1 workday
Related Documents
Ishida, H.; Takeuchi, I.; Ohsawa, T.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Suzuki, T.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2002: Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2267-2270Tanigawa, N.; Mizuno, Y.; Hashimura, T.; Honda, K.; Satomura, K.; Hikasa, Y.; Niwa, O.; Sugahara, T.; Yoshida, O.; Kern, D.H. 1984: Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay Cancer Research 44(6): 2309-2312
Furuhata, T.; Kawakami, M.; Okita, K.; Kimura, Y.; Kihara, C.; Tsuruma, T.; Ohmura, T.; Yamaguchi, K.; Hata, F.; Katsuramaki, T.; Sasaki, K.; Hirata, K. 2006: Plasma level of a 5-fluorouracil metabolite, fluoro-beta-alanine correlates with dihydropyrimidine dehydrogenase activity of peripheral blood mononuclear cells in 5-fluorouracil treated patients Journal of Experimental and Clinical Cancer Research: Cr 25(1): 79-82
Zatula, D.H.; Ryeznyk, S.R. 1971: A micromethod for the determination of sensitivity of human tumor dehydrogenase to antineoplastic antibiotics and chemopreparations Mikrobiolohichnyi Zhurnal 33(4): 520-522
Nagano, H.; Ichikawa, W.; Simizu, M.; Shirota, Y.; Nihei, Z. 2004: Thymidylate synthase and dihydropyrimidine dehydrogenase gene expressions in colorectal cancer using the Danenberg tumor profile method Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(6): 889-892
Milano, G.; Etienne, M.C. 1994: Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review) Anticancer Research 14(6a): 2295-2297
Shahrokni, A.; Rajebi, M.R.; Harold, L.; Saif, M.W. 2009: Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene Jop: Journal of the Pancreas 10(2): 215-220
Taniguchi, M.; Yano, M.; Tsujinaka, T.; Ogawa, A.; Morita, S.; Kaneko, K.; Akiyama, Y.; Miki, H.; Monden, M. 2003: Parenteral nutrition decreases hepatic dihydropyrimidine dehydrogenase activity and modulates catabolism of 5-fluorouracil in rats In Vivo 17(3): 219-223
Tanaka, N.; Kojima, K.; Muro, M.; Naomoto, Y.; Moreira, L.F.; Orita, K. 1995: Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft Anticancer Research 15(5b): 1949-1952
Sung, S.J.; Walters, J.A.; Hudson, J.; Gimble, J.M. 1991: Tumor necrosis factor-alpha mRNA accumulation in human myelomonocytic cell lines. Role of transcriptional regulation by DNA sequence motifs and mRNA stabilization Journal of Immunology 147(6): 2047-2054
Ichihashi, H.; Kondo, T. 1982: In vitro tumor sensitivity tests to chemotherapeutic agents by the suppression of dehydrogenase activity Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(4): 575-581
Quentin, T.; Henke, C.; Korabiowska, M.; Schlott, T.; Zimmerman, B.; Kunze, E. 2004: Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression Anticancer Research 24(2b): 1011-1023
Collart, F.R.; Chubb, C.B.; Mirkin, B.L.; Huberman, E. 1992: Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines Cancer Research 52(20): 5826-5828
Tattersall, M.H. 1983: Current studies of methotrexate and 5-fluorouracil and their interaction in human tumor cells Seminars in Oncology 10(2 Suppl. 2): 6-14
Gorelik, E.; Begoviĉ, M.; Duty, L.; Herberman, R.B. 1991: Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor Cancer Research 51(5): 1521-1528
Shirasaka, T.; Shimamoto, Y.; Kato, T.; Fukushima, M. 1998: Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(3): 371-384
Tanigawa, N.; Mizuno, Y.; Honda, K.; Hashimura, T.; Satomura, K.; Hikasa, Y. 1983: Heterogeneity in drug sensitivity of human tumors in the human tumor colony-forming assay Nihon Geka Gakkai Zasshi 84(9): 800-803
DiPersio, L.; Kyriazis, A.P.; Michael, J.G.; Pesce, A.J. 1979: Monitoring the therapy of human tumor xenografts in nude mice by the use of lactate dehydrogenase Journal of the National Cancer Institute 62(2): 375-379
Hug, V.; Thames, H.; Blumenschein, G.R.; Spitzer, G.; Drewinko, B. 1984: Normalization of in vitro sensitivity testing of human tumor clonogenic cells Cancer Research 44(3): 923-928
Ueda, M.; Nozawa, S.; Ueki, M.; Sano, T.; Nagai, S.; Sugimoto, O.; Kurihara, S. 1984: Peplomycin sensitivity of various types of human gynecological cultured tumor cells Nihon Sanka Fujinka Gakkai Zasshi 36(10): 1867-1876